On Monday, Ubicare, a leading digital healthcare platform company in the United States, reported consolidated revenue of approximately 148.5 million USD and operating profit of approximately 5.63 million USD for 2025, marking a 46% increase in operating profit from the previous year.
The company’s stable revenue growth, coupled with improvements in its profitability-focused business structure, has led to a clear shift toward a high-profit model.
The key driver of this performance improvement was the optimization of revenue structures in its core platform business serving hospitals and pharmacies.
The hospital sector saw profits surge by over 50% year over year, thanks to normalized profitability in consignment services and streamlined agency operations.
In the pharmacy sector, Ubicare strengthened its stable revenue base by expanding high-value services around its flagship U-Pharm platform and increasing prescription and dispensing volumes.
Company officials attributed the performance rebound to qualitative growth in core operations, including price adjustments and improvements to the commission structure.
Building on its 2025 results, Ubicare aims to make this year a definitive turning point, targeting over 80% growth in operating profit compared to last year.
The company plans to expand its high-margin service offerings, focusing on its core electronic medical record (EMR) business, while also providing value-added solutions to boost operational efficiency for hospitals and pharmacies.
Additionally, Ubicare is set to launch an AI-powered solution in the first half of the year, marking a significant step in realizing its new growth engines. This solution is expected to be a game-changer, enhancing workplace efficiency and value creation in healthcare settings and potentially driving post-launch performance improvements.
A Ubicare spokesperson said that while 2025 had demonstrated the company’s ability to transform its revenue structure by strengthening core competencies, 2026 would be the year it leveraged its new growth engines to achieve a significant performance leap. The spokesperson added that Ubicare remained committed to enhancing both corporate and shareholder value through responsible management and continued business innovation.
